Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
- Status
- TERMINATED
- Phase
- PHASE1
ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBM
- Status
- WITHDRAWN
- Phase
- N/A
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- PHASE3
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE1
HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM
- Status
- COMPLETED
- Phase
- PHASE2
Treatment Strategy for Low-grade Gliomas
- Status
- TERMINATED
- Phase
- PHASE3
Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine and Temozolomide for Neuroendocrine Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
- Status
- COMPLETED
- Phase
- PHASE2